BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33193355)

  • 1. "Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation".
    Cuvelier GDE; Li A; Drissler S; Kariminia A; Abdossamadi S; Rozmus J; Chanoine JP; Ng B; Mostafavi S; Brinkman RR; Schultz KR
    Front Immunol; 2020; 11():571884. PubMed ID: 33193355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
    Schultz KR; Kariminia A; Ng B; Abdossamadi S; Lauener M; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savasan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Azadpour S; Ostroumov E; Subrt P; Halevy A; Mostafavi S; Cuvelier GDE
    Blood; 2020 Apr; 135(15):1287-1298. PubMed ID: 32047896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
    Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
    J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study.
    Naeije L; Kariminia A; Abdossamadi S; Azadpour S; Subrt P; Kuzeljevic B; Irvine MA; Walker I; Schultz KR
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):438-444. PubMed ID: 31756535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.
    Forcade E; Kim HT; Cutler C; Wang K; Alho AC; Nikiforow S; Ho VT; Koreth J; Armand P; Alyea EP; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2016 May; 127(20):2489-97. PubMed ID: 26944544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
    Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
    Front Immunol; 2019; 10():1879. PubMed ID: 31507582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
    Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Role and Mechanism of Tfh and B Cell in Human Chronic Graft-Versus-Host-Disease].
    Lyu KK; Xu MM; DU YY; He XF; Chen F; Ma X; Han Y; Wu DP; Liu YJ; Xu MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):593-599. PubMed ID: 35396002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
    Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
    Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
    Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Perz JB; Gürel S; Schonland SO; Hegenbart U; Ho AD; Dreger P
    ScientificWorldJournal; 2012; 2012():606839. PubMed ID: 22666141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
    Rozmus J; Kariminia A; Abdossamadi S; Storer BE; Martin PJ; Lee SJ; Wolff D; Arora M; Cutler C; Schultz KR
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):451-458. PubMed ID: 30447393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.
    Knorr DA; Wang H; Aurora M; MacMillan ML; Holtan SG; Bergerson R; Cao Q; Weisdorf DJ; Cooley S; Brunstein C; Miller JS; Wagner JE; Blazar BR; Verneris MR
    Biol Blood Marrow Transplant; 2016 May; 22(5):825-33. PubMed ID: 26806586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease.
    Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation.
    Matos TR; Hirakawa M; Alho AC; Neleman L; Graca L; Ritz J
    Front Immunol; 2020; 11():570550. PubMed ID: 33537026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hu Y; Cui Q; Ye Y; Luo Y; Tan Y; Shi J; Huang H
    Hematol Oncol; 2017 Mar; 35(1):118-124. PubMed ID: 26439896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56bright CD16- natural killer cells as an important regulatory mechanism in chronic graft-
    Lauener M; AzadPour S; Abdossamadi S; Parthasarathy V; Ng B; Ostroumov E; Cuvelier GDE; Levings MK; MacDonald KN; Kariminia A; Schultz KR
    Haematologica; 2023 Mar; 108(3):761-771. PubMed ID: 36200416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.